ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,384 | -24.1% | 19,720 | +2.2% | 0.00% | -50.0% |
| Q1 2022 | $484,000 | +131.6% | 19,288 | +292.0% | 0.00% | +100.0% |
| Q3 2021 | $209,000 | -59.6% | 4,921 | -58.8% | 0.00% | -50.0% |
| Q2 2021 | $517,000 | +116.3% | 11,936 | +103.6% | 0.00% | +100.0% |
| Q1 2021 | $239,000 | -1.6% | 5,862 | +9.1% | 0.00% | -50.0% |
| Q4 2020 | $243,000 | -83.4% | 5,373 | -80.9% | 0.00% | -77.8% |
| Q4 2019 | $1,460,000 | +82.0% | 28,153 | +92.7% | 0.01% | +28.6% |
| Q3 2019 | $802,000 | +170.9% | 14,608 | +49.1% | 0.01% | +133.3% |
| Q1 2019 | $296,000 | -59.2% | 9,800 | -54.6% | 0.00% | -62.5% |
| Q4 2018 | $725,000 | +38.4% | 21,563 | +104.7% | 0.01% | 0.0% |
| Q1 2018 | $524,000 | +49.3% | 10,536 | +61.8% | 0.01% | +33.3% |
| Q4 2017 | $351,000 | -14.0% | 6,510 | -7.5% | 0.01% | -25.0% |
| Q3 2017 | $408,000 | +92.5% | 7,037 | +77.9% | 0.01% | -38.5% |
| Q2 2016 | $212,000 | – | 3,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |